United States · FDA National Drug Code directory
Ranolazine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-518_1524482d-40bd-a0f9-e063-6394a90a1a37
- Product NDC
- 71610-518
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- RANOLAZINE
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201027
- Source listing expiry
- 20261231
Source-listed ingredients
- RANOLAZINE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1800 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-518-42) · 71610-518-42
- 3600 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-518-83) · 71610-518-83
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →